Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
NCT04810182
·
clinicaltrials.gov ↗
COMPLETED
Status
192
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
Regorafenib 40 MG Oral Tablet [STIVARGA]
Sponsor
Istituto Oncologico Veneto IRCCS